Evolutionary genetics of tsetse and its symbionts
采采蝇及其共生体的进化遗传学
基本信息
- 批准号:8004935
- 负责人:
- 金额:$ 69.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-01-15 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdverse effectsAffectAfrica South of the SaharaAfricanAfrican TrypanosomiasisBacteriaBiologyChronicCommunity ParticipationCompetenceComplexDataDevelopmentDiagnosticDiseaseDisease VectorsEngineeringEpidemiologyEquilibriumFrightFutureGenesGeneticGenetic DriftGenetic ModelsGenetic StructuresGenotypeGoalsHumanInfectionInheritedKnowledgeLaboratoriesMediatingMidgutMitochondrial DNAModelingMonitorNatureOutcomeParasitesPatientsPatternPharmaceutical PreparationsPhenotypePopulationPopulation ControlPopulation GeneticsPrevalencePublic HealthRecombinantsRefractoryResearchResearch PersonnelResistanceStructureSystemTechnologyTestingTherapeuticTimeTransgenic OrganismsTrypanosomaTrypanosomiasisTsetse FliesUgandaVaccinesWolbachiabasedesigndisorder controlflyhuman diseaseinvertebrate hostkillingsnovelnovel strategiespopulation genetic structureprogramsreconstitutionresearch studysuccesstooltransmission processvector
项目摘要
DESCRIPTION (provided by applicant): Human African trypanosomiasis (HAT) kills thousands of people each year in sub-Saharan Africa. The disease is caused by African trypanosomes transmitted by the tsetse fly. HAT transmission is complex; it requires mammalian and invertebrate hosts and involves domestic and wild reservoirs. No mammalian vaccines exist and therapeutic drugs have serious side effects with increasing resistance seen in patients. In contrast, reduction of tsetse populations is highly efficacious for disease control. However, the implementation of the tsetse control programs, which rely on traps and targets, have been difficult to sustain because they are not practical and require extensive community participation. A paratransgenic strategy has been developed which exploits the unique biology of tsetse and its maternally inherited bacterial symbionts. In this strategy, tsetse's mutualist symbiont Sodalis is harnessed to express trypanosome inhibitory molecules in tsetse's midgut to impair trypanosome transmission. Transgenic Sodalis bacterium conferring refractoriness may be driven into natural tsetse populations by cytoplasmic incompatibility phenomenon mediated by tsetse's symbiont, Wolbachia. We propose to investigate the biogeography of the human disease vector species, Glossina fuscipes fuscipes, its Trypanosoma parasite(s), and its Wolbachia and Sodalis symbionts. Using a combination of laboratory and field experiments, we will investigate the potential for a Wolbachia mediated gene-drive mechanism to aid in the application of paratransgenic flies. In addition, we will elucidate the basic genetic structure of this human disease vector population, for which no information exists. This information is necessary for the efficacious implementation and monitoring of either the traditional or novel control strategies. Knowledge obtained on symbiont biology, maternal linkage of tsetse's multiple symbionts, Wolbachia infection phenotype, potential strength of Wolbachia mediated drive, population genetics and epidemiological dynamics will provide the parameters needed to develop a mathematically based model framework. This model will allow us to test the predictive nature of the empirical data, design the optimal strategies for population control, and predict feasibility and robustness for the success of the replacement strategy. This interdisciplinary application will combine epidemiology, population genetics and modeling with model parameterization and verification from laboratory and field research.
描述(由申请人提供):非洲人类锥虫病(HAT)每年在撒哈拉以南非洲造成数千人死亡。该病由采采蝇传播的非洲锥虫引起。HAT传输复杂;它需要哺乳动物和无脊椎动物宿主,包括家养和野生宿主。目前还没有哺乳动物疫苗,治疗药物有严重的副作用,患者的耐药性也在增加。相反,减少采采蝇种群对疾病控制非常有效。然而,依靠诱捕器和目标的采采蝇控制规划的实施很难持续下去,因为它们不实际,需要广泛的社区参与。利用采采蝇及其母系遗传细菌共生体的独特生物学特性,开发了一种准转基因策略。在这种策略中,利用采采蝇的共生共生菌Sodalis在采采蝇的中肠中表达锥虫抑制分子来破坏锥虫的传播。具有抗逆性的转基因Sodalis细菌可能是通过采采的共生体沃尔巴克氏体介导的细胞质不相容现象进入天然采采群体的。我们建议调查人类疾病媒介物种fuscipes fuscipes,其锥虫寄生虫及其Wolbachia和Sodalis共生体的生物地理学。利用实验室和现场实验相结合的方法,我们将研究沃尔巴克氏体介导的基因驱动机制在准转基因果蝇应用中的潜力。此外,我们将阐明这种人类病媒种群的基本遗传结构,目前尚无相关资料。这些信息对于有效实施和监测传统或新型控制策略都是必要的。关于共生体生物学、采采蝇多种共生体的母系连锁、沃尔巴克氏体感染表型、沃尔巴克氏体介导驱动的潜在强度、群体遗传学和流行病学动态的知识将为开发基于数学的模型框架提供所需的参数。该模型将允许我们检验经验数据的预测性,设计最优的人口控制策略,并预测替代策略成功的可行性和鲁棒性。这个跨学科的应用将结合流行病学、群体遗传学和模型参数化以及实验室和实地研究的验证。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Serap AKSOY其他文献
Serap AKSOY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Serap AKSOY', 18)}}的其他基金
Support for Vector Biology Training for Sustainable Control of Vector Borne diseases in East Africa
支持媒介生物学培训以可持续控制东非媒介传播疾病
- 批准号:
10675897 - 财政年份:2023
- 资助金额:
$ 69.07万 - 项目类别:
Molecular Aspects of Tsetse and Trypanosome Transmission
采采蝇和锥虫传播的分子方面
- 批准号:
10078239 - 财政年份:2019
- 资助金额:
$ 69.07万 - 项目类别:
Molecular Aspects of Tsetse and Trypanosome Transmission
采采蝇和锥虫传播的分子方面
- 批准号:
10297859 - 财政年份:2019
- 资助金额:
$ 69.07万 - 项目类别:
2015 Tropical Infectious Diseases Gordon Research Conference & Seminar
2015年热带传染病戈登研究会议
- 批准号:
8835890 - 财政年份:2015
- 资助金额:
$ 69.07万 - 项目类别:
Control of Tsetse Fly Transmitted Diseases in Kenya
肯尼亚采采蝇传播疾病的控制
- 批准号:
8985655 - 财政年份:2015
- 资助金额:
$ 69.07万 - 项目类别:
Expanding the toolbox for tsetse reproductive biology
扩展采采蝇生殖生物学的工具箱
- 批准号:
8789330 - 财政年份:2014
- 资助金额:
$ 69.07万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 69.07万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 69.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 69.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 69.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 69.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 69.07万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 69.07万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 69.07万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 69.07万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 69.07万 - 项目类别:
Discovery Grants Program - Individual